Somatostatin Receptor Type 2 Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 CRN-00808
1.2.3 Lanreotide Acetate
1.2.4 PRL-2903
1.2.5 Others
1.3 Market by Application
1.3.1 Global Somatostatin Receptor Type 2 Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Somatostatin Receptor Type 2 Market Perspective (2017-2028)
2.2 Somatostatin Receptor Type 2 Growth Trends by Region
2.2.1 Somatostatin Receptor Type 2 Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Somatostatin Receptor Type 2 Historic Market Size by Region (2017-2022)
2.2.3 Somatostatin Receptor Type 2 Forecasted Market Size by Region (2023-2028)
2.3 Somatostatin Receptor Type 2 Market Dynamics
2.3.1 Somatostatin Receptor Type 2 Industry Trends
2.3.2 Somatostatin Receptor Type 2 Market Drivers
2.3.3 Somatostatin Receptor Type 2 Market Challenges
2.3.4 Somatostatin Receptor Type 2 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Somatostatin Receptor Type 2 Players by Revenue
3.1.1 Global Top Somatostatin Receptor Type 2 Players by Revenue (2017-2022)
3.1.2 Global Somatostatin Receptor Type 2 Revenue Market Share by Players (2017-2022)
3.2 Global Somatostatin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Somatostatin Receptor Type 2 Revenue
3.4 Global Somatostatin Receptor Type 2 Market Concentration Ratio
3.4.1 Global Somatostatin Receptor Type 2 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Somatostatin Receptor Type 2 Revenue in 2021
3.5 Somatostatin Receptor Type 2 Key Players Head office and Area Served
3.6 Key Players Somatostatin Receptor Type 2 Product Solution and Service
3.7 Date of Enter into Somatostatin Receptor Type 2 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Somatostatin Receptor Type 2 Breakdown Data by Type
4.1 Global Somatostatin Receptor Type 2 Historic Market Size by Type (2017-2022)
4.2 Global Somatostatin Receptor Type 2 Forecasted Market Size by Type (2023-2028)
5 Somatostatin Receptor Type 2 Breakdown Data by Application
5.1 Global Somatostatin Receptor Type 2 Historic Market Size by Application (2017-2022)
5.2 Global Somatostatin Receptor Type 2 Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Somatostatin Receptor Type 2 Market Size (2017-2028)
6.2 North America Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
6.3 North America Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Somatostatin Receptor Type 2 Market Size (2017-2028)
7.2 Europe Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
7.3 Europe Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Somatostatin Receptor Type 2 Market Size (2017-2028)
8.2 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
8.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Somatostatin Receptor Type 2 Market Size (2017-2028)
9.2 Latin America Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
9.3 Latin America Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Somatostatin Receptor Type 2 Market Size (2017-2028)
10.2 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2017-2022)
10.3 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amryt Pharma plc
11.1.1 Amryt Pharma plc Company Detail
11.1.2 Amryt Pharma plc Business Overview
11.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Introduction
11.1.4 Amryt Pharma plc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
11.1.5 Amryt Pharma plc Recent Development
11.2 Crinetics Pharmaceuticals Inc
11.2.1 Crinetics Pharmaceuticals Inc Company Detail
11.2.2 Crinetics Pharmaceuticals Inc Business Overview
11.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Introduction
11.2.4 Crinetics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
11.2.5 Crinetics Pharmaceuticals Inc Recent Development
11.3 Daewoong Pharmaceutical Co Ltd
11.3.1 Daewoong Pharmaceutical Co Ltd Company Detail
11.3.2 Daewoong Pharmaceutical Co Ltd Business Overview
11.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Introduction
11.3.4 Daewoong Pharmaceutical Co Ltd Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
11.3.5 Daewoong Pharmaceutical Co Ltd Recent Development
11.4 Ipsen SA
11.4.1 Ipsen SA Company Detail
11.4.2 Ipsen SA Business Overview
11.4.3 Ipsen SA Somatostatin Receptor Type 2 Introduction
11.4.4 Ipsen SA Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
11.4.5 Ipsen SA Recent Development
11.5 Progenics Pharmaceuticals Inc
11.5.1 Progenics Pharmaceuticals Inc Company Detail
11.5.2 Progenics Pharmaceuticals Inc Business Overview
11.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Introduction
11.5.4 Progenics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
11.5.5 Progenics Pharmaceuticals Inc Recent Development
11.6 Strongbridge Biopharma plc
11.6.1 Strongbridge Biopharma plc Company Detail
11.6.2 Strongbridge Biopharma plc Business Overview
11.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Introduction
11.6.4 Strongbridge Biopharma plc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
11.6.5 Strongbridge Biopharma plc Recent Development
11.7 Zucara Therapeutics Inc
11.7.1 Zucara Therapeutics Inc Company Detail
11.7.2 Zucara Therapeutics Inc Business Overview
11.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Introduction
11.7.4 Zucara Therapeutics Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022)
11.7.5 Zucara Therapeutics Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of CRN-00808
Table 3. Key Players of Lanreotide Acetate
Table 4. Key Players of PRL-2903
Table 5. Key Players of Others
Table 6. Global Somatostatin Receptor Type 2 Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Somatostatin Receptor Type 2 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Somatostatin Receptor Type 2 Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Somatostatin Receptor Type 2 Market Share by Region (2017-2022)
Table 10. Global Somatostatin Receptor Type 2 Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Somatostatin Receptor Type 2 Market Share by Region (2023-2028)
Table 12. Somatostatin Receptor Type 2 Market Trends
Table 13. Somatostatin Receptor Type 2 Market Drivers
Table 14. Somatostatin Receptor Type 2 Market Challenges
Table 15. Somatostatin Receptor Type 2 Market Restraints
Table 16. Global Somatostatin Receptor Type 2 Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Somatostatin Receptor Type 2 Market Share by Players (2017-2022)
Table 18. Global Top Somatostatin Receptor Type 2 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatostatin Receptor Type 2 as of 2021)
Table 19. Ranking of Global Top Somatostatin Receptor Type 2 Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Somatostatin Receptor Type 2 Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Somatostatin Receptor Type 2 Product Solution and Service
Table 23. Date of Enter into Somatostatin Receptor Type 2 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Somatostatin Receptor Type 2 Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2017-2022)
Table 27. Global Somatostatin Receptor Type 2 Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2023-2028)
Table 29. Global Somatostatin Receptor Type 2 Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2017-2022)
Table 31. Global Somatostatin Receptor Type 2 Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2023-2028)
Table 33. North America Somatostatin Receptor Type 2 Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Somatostatin Receptor Type 2 Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Somatostatin Receptor Type 2 Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Somatostatin Receptor Type 2 Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Somatostatin Receptor Type 2 Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Somatostatin Receptor Type 2 Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2023-2028) & (US$ Million)
Table 43. Amryt Pharma plc Company Detail
Table 44. Amryt Pharma plc Business Overview
Table 45. Amryt Pharma plc Somatostatin Receptor Type 2 Product
Table 46. Amryt Pharma plc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
Table 47. Amryt Pharma plc Recent Development
Table 48. Crinetics Pharmaceuticals Inc Company Detail
Table 49. Crinetics Pharmaceuticals Inc Business Overview
Table 50. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product
Table 51. Crinetics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
Table 52. Crinetics Pharmaceuticals Inc Recent Development
Table 53. Daewoong Pharmaceutical Co Ltd Company Detail
Table 54. Daewoong Pharmaceutical Co Ltd Business Overview
Table 55. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product
Table 56. Daewoong Pharmaceutical Co Ltd Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
Table 57. Daewoong Pharmaceutical Co Ltd Recent Development
Table 58. Ipsen SA Company Detail
Table 59. Ipsen SA Business Overview
Table 60. Ipsen SA Somatostatin Receptor Type 2 Product
Table 61. Ipsen SA Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
Table 62. Ipsen SA Recent Development
Table 63. Progenics Pharmaceuticals Inc Company Detail
Table 64. Progenics Pharmaceuticals Inc Business Overview
Table 65. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product
Table 66. Progenics Pharmaceuticals Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
Table 67. Progenics Pharmaceuticals Inc Recent Development
Table 68. Strongbridge Biopharma plc Company Detail
Table 69. Strongbridge Biopharma plc Business Overview
Table 70. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product
Table 71. Strongbridge Biopharma plc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
Table 72. Strongbridge Biopharma plc Recent Development
Table 73. Zucara Therapeutics Inc Company Detail
Table 74. Zucara Therapeutics Inc Business Overview
Table 75. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product
Table 76. Zucara Therapeutics Inc Revenue in Somatostatin Receptor Type 2 Business (2017-2022) & (US$ Million)
Table 77. Zucara Therapeutics Inc Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Somatostatin Receptor Type 2 Market Share by Type: 2021 VS 2028
Figure 2. CRN-00808 Features
Figure 3. Lanreotide Acetate Features
Figure 4. PRL-2903 Features
Figure 5. Others Features
Figure 6. Global Somatostatin Receptor Type 2 Market Share by Application in 2021 & 2028
Figure 7. Hormonal Disorder Case Studies
Figure 8. Oncology Case Studies
Figure 9. Metabolic Disorder Case Studies
Figure 10. Others Case Studies
Figure 11. Somatostatin Receptor Type 2 Report Years Considered
Figure 12. Global Somatostatin Receptor Type 2 Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Somatostatin Receptor Type 2 Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Somatostatin Receptor Type 2 Market Share by Region: 2021 VS 2028
Figure 15. Global Somatostatin Receptor Type 2 Market Share by Players in 2021
Figure 16. Global Top Somatostatin Receptor Type 2 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatostatin Receptor Type 2 as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Somatostatin Receptor Type 2 Revenue in 2021
Figure 18. North America Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Somatostatin Receptor Type 2 Market Share by Country (2017-2028)
Figure 20. United States Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Somatostatin Receptor Type 2 Market Share by Country (2017-2028)
Figure 24. Germany Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Somatostatin Receptor Type 2 Market Share by Region (2017-2028)
Figure 32. China Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Somatostatin Receptor Type 2 Market Share by Country (2017-2028)
Figure 40. Mexico Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Somatostatin Receptor Type 2 Market Share by Country (2017-2028)
Figure 44. Turkey Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Somatostatin Receptor Type 2 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Amryt Pharma plc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
Figure 47. Crinetics Pharmaceuticals Inc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
Figure 48. Daewoong Pharmaceutical Co Ltd Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
Figure 49. Ipsen SA Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
Figure 50. Progenics Pharmaceuticals Inc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
Figure 51. Strongbridge Biopharma plc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
Figure 52. Zucara Therapeutics Inc Revenue Growth Rate in Somatostatin Receptor Type 2 Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Industry Market Size
